Zha, Mingming http://orcid.org/0000-0001-7208-1514
Huang, Kangmo http://orcid.org/0000-0003-1354-5459
Yang, Dong
Xiao, Lulu
Cai, Haodi
Yang, Qingwen
Liu, Rui
Liu, Xinfeng
Funding for this research was provided by:
Strokecare medical Co.,LTD, Shanghai, China.
Article History
Accepted: 5 October 2020
First Online: 20 October 2020
Compliance with ethical standards
:
: The original study (identifying the non-inferiority of multi-stent Captor™ stent to Solitaire™ FR retriever, register code: ChiCTR1900025256) was funded by Strokecare medical Co.,LTD, Shanghai, China. Prof. Xinfeng Liu served as the principal investigator for the Captor Clinical Trial sponsored by Shanghai Strokecare Medical Co.LTD. He also reported personal fees from Medtronic and speaker fees from Medtronic, Abbott, and Johnson & Johnson, outside the submitted work. Dr. Rui Liu served as a researcher for the Captor Clinical Trial and provided consultation to Shanghai Strokecare Medical Co.LTD.
: The original study was proved by the ethnic committee of Jinling Hospital and participating centers (2017NZQX-002–01). This study was approved by the institutional ethics committee, which also waived informed consent due to the retrospective nature of this study.
: Informed consent was obtained from each patient or their representative.
: All the authors have approved the manuscript and agree with submission to your esteemed journal.